Repetitive Transcranial Magnetic Stimulation, a Form of Non-invasive Brain Stimulation, as a Possible Treatment for Post-stroke Fatigue.
Part of paid clinical trials in Decatur, Georgia.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT05584124
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Fatigue
- Stroke
- Stroke, Chronic
Eligibility Criteria
- Sex
- ALL
- Age
- 34 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- High frequency repetitive transcranial magnetic stimulation — DEVICEMagVenture MagPro X100 with MagOption
- Sham repetitive transcranial magnetic stimulation — DEVICEMagVenture MagPro X100 with MagOption
Study Details
This experimental trial is investigating the use of magnetic stimulation of the brain as a possible treatment for post-stroke fatigue in people who have had a stroke more than six months prior to enrolling. Fatigue is a common condition after a stroke and can negatively impact an individual's ability to perform desired social and physical activities. Magnetic stimulation of the brain has been shown to improve signs and symptoms of related psychological (e.g., depression) conditions. Participants in this trial will receive a type of magnetic stimulation called repetitive transcranial magnetic stimulation, or rTMS. The investigators will measure feelings of fatigue and other clinical characteristics related to mood and cognition before and after participants receive rTMS.
Key Dates
- Start date
- Apr 10, 2023
- Status verified
- Apr 2026
- Primary completion
- Oct 29, 2027
- Completion
- Oct 29, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Real M1 High Frequency rTMSParticipants will be randomly assigned to receive high-frequency repetitive transcranial magnetic stimulation (rTMS) to the top of their head for approximately 40 minutes.
- Sham Comparator: Sham rTMSParticipants will be randomly assigned to receive sham/placebo repetitive transcranial magnetic stimulation (rTMS) to the their head for approximately 40 minutes. This is a control condition.
Primary Outcome Measure
Change in Fatigue Severity Scale (FSS) score [ Time Frame: Change from baseline FSS score to 7 days after last treatment ]
Central Contacts
- John H Kindred(970) 426-9350
- Christina Young(404) 432-6111
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Atlanta VA Medical and Rehab Center, Decatur, GA | Decatur | Georgia | 30033-4004 | John H Kindred (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Decatur, GA
Related Studies
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen DeficiencyPHASE2 · Recruiting · Seattle Institute for Biomedical and Clinical Research · Augusta, Georgia
- Stroke Thrombectomy and Aneurysm RegistryRecruiting · Medical University of South Carolina · Birmingham, Alabama